Erik A Imel
Overview
Explore the profile of Erik A Imel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
3071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali D, Carpenter T, Imel E, Ward L, Appelman-Dijkstra N, Chaussain C, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39960858
Background: An International Working Group (IWG) developed new guidelines on the diagnosis, evaluation, management, and monitoring of X-linked hypophosphatemia (XLH) in children. Over the past 5 years, important advances have...
2.
Ali D, Mirza R, Hussein S, Alsarraf F, Alexander R, Abu Alrob H, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39787354
Objective: To examine the evidence addressing the management of X-linked hypophosphatemia (XLH) in children to inform treatment recommendations. Methods: We searched Embase, MEDLINE, Web of Science, and Cochrane Central up...
3.
Ali D, Mirza R, Alsarraf F, Hussein S, Abu Alrob H, Appelman-Dijkstra N, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39715351
Objective: To examine the highest certainty evidence addressing the management of X-linked hypophosphatemia (XLH) in adults to inform treatment recommendations. Methods: We searched Embase, MEDLINE, Web of Science, and Cochrane...
4.
Luo X, Ding H, Warden S, Moorthi R, Imel E
Health Informatics J
. 2024 Nov;
30(4):14604582241300025.
PMID: 39611362
Patients with sarcopenia often go undetected in busy clinical practices since the muscle measurements are not easily incorporated into routine clinical practice. The current research fills the gap by utilizing...
5.
Imel E, Li Z, Heerssen H, Princic N, Schwartz H, Zhao Y, et al.
J Endocr Soc
. 2024 Nov;
8(12):bvae185.
PMID: 39539413
Objective: To examine the real-world clinical and healthcare resource burden of familial hypophosphatemia (FH). Methods: In a retrospective, observational cohort study using MarketScan claims data from 2017 to 2021, clinical...
6.
Thompson H, Hubbard M, Ackah S, Dewey A, Zevin E, Imel E, et al.
Int J Pediatr Otorhinolaryngol
. 2024 Oct;
186:112116.
PMID: 39362056
No abstract available.
7.
Portale A, Ward L, Dahir K, Florenzano P, Ing S, de Beur S, et al.
J Bone Miner Res
. 2024 Aug;
39(10):1493-1502.
PMID: 39151033
Background: In patients with X-linked hypophosphatemia (XLH), conventional therapy with oral phosphate salts and active vitamin D has been associated with nephrocalcinosis. However, the nature of the relationships among XLH,...
8.
Jodeh W, Sparks P, Higgins J, Tom A, Anilovich N, Moit H, et al.
JBMR Plus
. 2024 Jul;
8(8):ziae083.
PMID: 39035786
Maternal Parathyroid Hormone-related Protein (PTHrP) is involved in the placental transport of calcium. Autonomous overproduction of PTHrP is a rare cause of hypercalcemia in pregnancy. Prior cases of PTHrP-induced hypercalcemia...
9.
Davis K, Imel E, Kelley J
J Bone Miner Res
. 2024 Jul;
39(7):821-825.
PMID: 38988138
An 18-month-old male presented with gross motor delay and poor growth (weight z-score -2.21, length z-score -4.26). Radiographs showed metaphyseal irregularities suggesting metaphyseal dysplasia and sagittal craniosynostosis. Biochemical evaluation supported...
10.
de Beur S, Dahir K, Imel E, Zanchetta M, Williams A, Li Z, et al.
J Clin Endocrinol Metab
. 2024 Jun;
110(1):102-113.
PMID: 38913723
Context: Tumor-induced osteomalacia (TIO) is an ultra-rare, paraneoplastic syndrome caused by tumors that secrete fibroblast growth factor 23 (FGF23). Initial signs and musculoskeletal symptoms can be nonspecific and unrecognized, leading...